Delivery Order SPE2DR25D1205-SPE2DR26F0XT5
- Not listed
- The Defense Logistics Agency awarded a $1,941.48 delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of OxyContin ER 40 mg tablets in quantities of 100 units. This firm fixed-price, non-set-aside contract is scheduled for completion by November 13, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order against AmerisourceBergen's larger contract vehicle with DLA. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of OxyContin ER 40 mg tablets (100-count units) with a contract ceiling value of $8,112.79. This non-competitive, firm fixed-price delivery order is scheduled for completion by November 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $8,292.15 delivery order to AmerisourceBergen Drug Corp for OxyContin ER 40 mg tablets (100-count units) on September 15, 2025, with an ultimate completion date of September 16, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply agreements. The product will be delivered to the company's Conshohocken, Pennsylvania facility, which serves as the prime...
- The Defense Logistics Agency awarded a delivery order valued at $10,805.40 to AmerisourceBergen Drug Corp for OxyContin ER 40 mg tablets (100-count units) on September 8, 2025, with an ultimate completion date of September 9, 2025. This competitively awarded, firm fixed-price contract requires no set-aside designation and specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,640.14 to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count packages) on December 8, 2025, with an ultimate completion date of December 9, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,577.23 to AmerisourceBergen Drug Corp for the supply of OxyContin ER 40 mg tablets (100 count) on September 23, 2025, with completion scheduled for September 24, 2025. This is a firm fixed-price, non-set-aside delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for OxyContin ER 20 mg tablets (100 count) valued at $4,784.56. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for completion by November 5, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,733.21 to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) on August 25, 2025, with ultimate completion by August 26, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs across...
- The Defense Logistics Agency awarded a delivery order valued at $1,451.16 to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) on August 20, 2025, with an ultimate completion date of August 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The place of performance is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a $1,256.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) on May 23, 2025, with a completion date of May 27, 2025. This non-set-aside competitive award was placed for performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- SPE2DR25D1205Indefinite Delivery Contract
- SPE2DR25D1205-SPE2DR26F0XT5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,837.42 to AmerisourceBergen Drug Corp for OxyContin ER 40 mg tablets (100-count packages) on December 5, 2025, with an ultimate completion date of December 8, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Health Agency and other government entities. The company's federal contract portfolio demonstrates extensive experience delivering a wide range of pharmaceutical products across multiple therapeutic domains under competitive procurement mechanisms. This specific delivery order for controlled-substance pain management medication reflects the company's ongoing role in supplying essential pharmaceuticals to support Department of Defense healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 12/4/25 |